ACI is involved in a clinical trial in which dogs who are scheduled for amputation with a diagnosis of osteosarcoma will have tumor samples collected and analyzed. Dogs of all breed, ages, and sex are eligible. This study serves to evaluate the quality of samples collected from Osteosarcoma bone tumors from dogs for genomic profiling. Samples will be collected following the amputation procedure.

Dogs with suspected primary appendicular Osteosarcoma (based on physical exam or radiographs) or confirmed diagnosis (based on previous cytology or histopathology of the affected limb (+/- metastisis) of appendicular Osteosarcoma with a planned amputation are eligible for this trial.

An eligible dog must not have received previous treatment for cancer, including chemotherapy, bisphosphonate therapy, prednisone therapy, radiation therapy or immunotherapy, other than Non-Steroid Anti-Inflammatory Drugs (NSAIDs). Concurrent acupuncture is permitted, though the patient must have began acupuncture treatment > 2 weeks prior to sample collection.

Following amputation, patients are eligible to receive treatment as chosen by the owner, including enrollment in another clinical trial. In appreciation of participation, $500 will be provided to the pet owner to offset a portion of the amputation costs.

(SPECIAL INTEREST IN GREYHOUNDS)

Trial Participation

All Metro DC Veterinary Clinics